Related Experiment Video
Updated: Jul 10, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Update: new uses for lithium and anticonvulsants
Jennifer M Rosenberg1, Carl Salzman
1Front Range Clinical Research, Wheat Ridge, CO, USA.
CNS Spectrums
|November 7, 2007
Summary
Anticonvulsants show promise for anxiety disorders, particularly PTSD, and are explored as alternatives for substance use withdrawal. Evidence for their use in schizophrenia remains inconclusive.
Area of Science:
- Psychiatry
- Clinical Pharmacology
- Neuroscience
Background:
- Anticonvulsants are increasingly used for mental health conditions beyond mood disorders.
- Benzodiazepines present challenges in managing alcohol and benzodiazepine withdrawal.
- Anticonvulsants are being investigated as potential alternatives for these withdrawal syndromes.
Purpose of the Study:
- To review the literature on anticonvulsants and lithium in substance use disorders, anxiety disorders, and schizophrenia.
- To evaluate the efficacy of anticonvulsants as alternatives to benzodiazepines in withdrawal management.
- To assess the role of anticonvulsant and lithium augmentation in schizophrenia treatment.
Main Methods:
- Literature review of studies on anticonvulsants and lithium.
- Focus on randomized controlled trials and clinical practice data.
- Analysis of evidence for anxiety disorders, substance use disorders, and schizophrenia.
Main Results:
- Anticonvulsants demonstrate promising therapeutic effects in various anxiety disorders, especially posttraumatic stress disorder (PTSD).
- Studies on anticonvulsant and lithium augmentation for schizophrenia, despite being common practice and rigorously studied, have yielded inconclusive results.
- Anticonvulsants are considered as alternatives for alcohol and benzodiazepine withdrawal due to benzodiazepine limitations.
Conclusions:
- Anticonvulsants offer potential benefits for anxiety disorders and substance withdrawal management.
- The current evidence does not support the routine use of anticonvulsant or lithium augmentation for schizophrenia.
- Further research is needed to clarify the role of these agents in specific psychiatric conditions.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications